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ABSTRACT  
The development of robust suspension cultures of human embryonic stem cells (hESCs) without the use 
of cell membrane disrupting enzymes or inhibitors is critical for future clinical applications in 
regenerative medicine.  We have achieved this by using long, flexible and thermoresponsive polymer 
worms decorated with a recombinant vitronectin subdomain that bridge hESCs, aiding in hESC’s 
natural ability to form embryoid bodies (EBs) and satisfying their inherent requirement for cell-cell and 
cell-extracellular matrix contact. When the EBs reached an optimal upper size where cytokine and 
nutrient penetration becomes limiting, these long and flexible polymer worms facilitated EB breakdown 
via a temperature shift from 37 to 25 oC. The thermoresponsive nature of the worms enabled a cyclical 
dissociation and propagation of the cells. Repeating the process for three cycles (over eighteen days) 
provided a >30 fold expansion in cell number while maintaining pluripotency, thereby providing a 
simple, non-destructive process for the 3D expansion of hESC. 
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INTRODUCTION 
Development of fully defined conditions for reproducible and scalable production of undifferentiated 
human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) remains a significant 
challenge for the production of cell sources for regenerative therapies, drug screening, tissue 
engineering and the study of disease progression.1, 2 To date, the most common methods for the 
propagation of stem cells involve growing the cells on feeder layers followed by manual dissection for 
sub-culturing or growth on two dimensional (2D) surfaces functionalized with either (i) an extract of 
extracellular matrix (ECM) derived from a murine tumor cell line, (ii) more defined extracellular matrix 
components, or (iii) recombinant ECM fragments.3, 4, 5-7 Microcarriers (MCs) represent a method to 
increase the surface area many fold (on the order of 4,000 cm2 per gram) and can be suspended in mixed 
liquid culture, allowing good control of environmental conditions.8 An alternative technique for cell 
expansion utilizes the natural ability of hESCs to aggregate in well-defined media to form embryoid 
bodies (EBs),9 allowing the cells to be grown in three dimensions.  The cell aggregates can be grown in 
suspension culture allowing good environmental control whilst maintaining cell-cell contact, which is 
critical for long-term cell survival. When stem cells are grown in this fashion, the aggregates (EBs) must 
be limited to sizes where nutrients and cytokines can penetrate to all cells, and by-products can be 
removed through diffusion to allow for maintenance of an undifferentiated state and self-renewal of the 
cells.10, 11  
A major hurdle with all the above approaches is the difficulty in dissociating the cells into either 
single cells or small cell aggregates without membrane disrupting enzymes; a necessary requirement for 
sub-culturing and especially cell expansion. Sub-culturing techniques generally rely on cell detachment 
and dissociation from other cells and from 2D or 3D surfaces with enzymatic (e.g. trypsin or accutase) 
or chemical treatment (e.g. EDTA). Additionally, ROCK inhibitor or other small molecules are often 
used to significantly reduce cell apoptosis and improve self-renewal after each passage.9, 12, 13 These 
added enzymes and inhibitors concomitantly modify the cell surface structure and signaling pathways, 
thereby impacting on future cell behavior and fate.12-14 To overcome the requirement for enzymatic 
 4 
mediated cell dissociation, thermoresponsive polymers (e.g. poly(N-isopropylacrylamide (PNIPAM)15) 
grafted onto 2D surfaces16, 17, 18 or MCs19, 20 have provided an elegant means to release the cells on-
demand by simply decreasing the temperature without enzymatic or chemical treatments.  For example, 
by decreasing the temperature from 37 oC to below the lower critical solution temperature (LCST) of 
PNIPAM, mammalian cells could be released without enzymatic treatment.20 However, 
thermoresponsive polymers coated onto surfaces for mouse and human embryonic stem cell growth 
have had limited success in expansion due to the limited surface area available for culturing on 2D 
surfaces or MCs and in many cases required the use of undefined surface matrices.16, 18, 21, 22 
We report here, a system that enables reproducible growth and greater than 30-fold expansion in 
hESCs numbers while maintaining an undifferentiated hESC phenotype and the ability for these cells to 
undergo controlled cellular differentiation. We utilize thermoresponsive polymer worm nanostructures 
to bridge hESCs, aggregating them into EBs with good cell-cell contact and excellent nutrient 
penetration. Once the cells grow and reach EB diameter where nutrient penetration becomes restricted,10 
the EBs are broken down to small aggregates by decreasing the temperature. These small aggregates are 
then equally split into three (i.e. passaged), after which the small EBs reformed with the aid of the 
polymer worms and allowed to grow. This passaging process is repeated several times providing a 
reproducible method for hESCs expansion. 
The novel polymer worm structure used in this work was synthesized through a one-pot reversible 
addition fragmentation chain transfer (RAFT) polymerization of styrene using a PNIPAM MacroCTA in 
water.23 After polymerization, the worms were formed through a temperature directed morphology 
transformation (TDTM) process.24 The resulted nanostructure consisted of a hard (i.e. glassy) 
polystyrene core decorated with a dense coating of PNIPAM chains on the surface (denoted here as 
pBridges)23, 24 that when heated to 37 oC in the presence of a cell binding vitronectin fragment5 coupled 
to a PNIPAM chain (i.e. a diblock copolymer of PNIPAM-b-VN) facilitated the formation and growth 
of an EB (schematically represented in Figure 1A). Importantly, by simply reducing the temperature of 
the culture, it was possible for the cell aggregate within the EB to break down under gentle pipetting 
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conditions to smaller sized aggregates. These smaller aggregates were split equally into three larger 
culture volumes and when heated back to 37 oC with the addition of new worms and PNIPAM-b-VN 
allowed for the regeneration of EBs and further cell growth (Figure 1B). This process all the while 
maintained contact between cells and facilitated cell-ECM interaction through the bound PNIPAM-b-
VN. The ability to cycle between larger EBs, where there was a danger of the nutrients becoming 
limiting, to smaller EBs resulted in a method of expanding the number of stem cells without the need for 
any enzymatic or chemical intervention at the sub-culturing stage. The extremely low concentration of 
worms (~1.56 ng/mL), with an average length of 2 μm and a diameter of 10 nm, acted to both aggregate 
the cells above PNIPAM’s LCST and aid in the on-demand cell release when the temperature was 
lowered below the LCST. The PNIPAM-b-VN allowed binding of the VN fragment with the cells and 
adsorption of the PNIPAM block to the worms above the LCST; a process that was fully reversible 
upon cooling. This passaging method and growth of EBs allowed controlled stem cell expansion under 
fully defined conditions (see a schematic in Figure 1C).  
METHODS 
Polymer Synthesis: 
 
Materials. 
Solvents used were HPLC or AR grade. Activated basic alumina (Aldrich: Brockmann I, standard 
grade, ~ 150 mesh, 58 Å), Milli-Q water (Biolab, 18.2 MΩ.cm), sodium dodecyl sulphate (SDS: 
Aldrich, 99 %) were used as received. Styrene (STY: Aldrich, >99 %) was passed through a basic 
alumina column to remove inhibitor. N-isopropylacrylamide (NIPAM: Aldrich, 97 %) and 
azobisisobutyronitrile (AIBN: Riedel-de Haen) were recrystallised from hexane, and methanol, 
respectively, prior to use. Carbondisulfide (99%), 1-butanethiol (99%), methyl bromopropionate (98%), 
dimethyl sulfoxide (DMSO, >99.9%), AldrithilTM-2 (98%), hexylamine (99%) were used as received 
from Aldrich. Triethyleneamine (>99%) was used as received from Merck Millipore. The RAFT agent 
methyl 2-(butylthiocarbonothioylthio)propanoate was synthesized according the literature procedure.25   
Size Exclusion Chromatography (SEC)  
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SEC measurements were performed using a Waters Alliance 2690 Separations Module equipped with 
an auto-sampler, Differential Refractive Index (RI) detector and a Photo Diode Array (PDA) detector 
connected in series. HPLC grade tetrahydrofuran was used as eluent at flow rate 1 mL/min. The 
columns consisted of two 7.8 x 300 mm Waters linear Ultrastyragel SEC columns connected in series. 
Polystyrene standards were used for calibration. 
Transmission Electron Microscopy (TEM)  
The polymer worms were analyzed using a JEOL-1010 transmission electron microscope utilizing an 
accelerating voltage of 100 kV with spot size 6 at ambient temperature. A typical TEM grid preparation 
was as follows: the worms were dispersed in diluted Milli-Q water to approximately 0.05 wt%. A 
formvar pre-coated copper TEM grid was then dipped in the diluted latex solution and dried on filter 
paper at 25 °C. See Figure S4A. 
Scanning Electron Microscopy (SEM) 
An aqueous solution of worms (0.05 wt %) were dropped onto a silicon chip and allowed to dry under 
vacuum. It was imaged uncoated in a JEOL JSM-7800F field emission SEM at 1kV accelerating 
voltage. The sample was then imaged with the in-lens Upper Electron Detector (UED) with a positive 
bias filter that allowed the detection of both secondary and backscattered electrons for image formation. 
The stage was also given a negative bias, gentle beam (GB) mode, to reduce chromatic aberration and 
increase electron emission from the sample. See Figure S4B 
1H Nuclear Magnetic Resonance (NMR) Spectroscopy  
All NMR spectra were recorded on a Bruker DRX 500 MHz spectrometer using an external lock 
(CDCl3) and referenced to the undeuterated solvent (CHCl3). 
Matrix-Assisted Laser Desorption Ionization-Time-of-Flight (MALDI-ToF) Mass Spectrometry 
MALDI-ToF MS spectra were obtained using a Bruker MALDI-ToF autoflex III smart beam 
equipped with a nitrogen laser (337 nm, 200 Hz maximum firing rate) with a mass range of 600-400,000 
Da. Spectra were recorded in both reflectron mode (2,000-5,000 Da) and linear mode (5,000-20,000 
Da).  Trans-2-[3-(4-tert-butylphenyl)-2-methyl-propenylidene] malononitrile (DCTB; 20 mg/mL in 
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THF) was used as the matrix and Na(CF3COO) (1 mg/mL in THF) as the cation source. Samples were 
prepared by co-spotting 1 µL mixture of the matrix (20 μL), Na(CF3COO) (1 μL), and polymer (20 μL, 
1 mg/mL in THF) solutions on the target plate. 
Synthesis of PNIPAM43-SC(=S)SC4H9 by RAFT Polymerization. 
NIPAM (15 g, 0.133 mol), RAFT agent (methyl 2-(butylthiocarbonothioylthio)propanoate; 0.75 g 3.0 
x 10-3 mol) and AIBN (50 mg, 3.0 x 10-4 mol) were dissolved in 30 mL DMSO in a 50 mL Schlenk 
flask. The solution was purged with Ar for 30 min. The reaction solution was then immersed in 
preheated oil-bath at 60 oC for 16 h. The reaction was stopped by cooling in an ice-bath and exposing 
the solution to air. The polymerization mixture was then diluted with 500 mL DCM and washed with 
Milli-Q water five times. The organic phase was dried over MgSO4, filtered, concentrated and 
precipitated in diethyl ether. After filtration, the yellow powder was dried under vacuum at R.T. for 48 
h. (Mn,GPC = 4200, PDI = 1.09). 
1H NMR (CDCl3, 298K, 500 MHz); 6.47 (b, -NH-C=O- of poly(NIPAM) repeating units), 3.97 (b, -
NH-CH(CH3)2 of poly(NIPAM) repeating units), 4.62 (b, 1H, -CH-SC(=S)S-C4H9), 3.97 (b, -NH-
CH(CH3)2 of poly(NIPAM) repeating units), 3.66 (b, 3H, CH3O- RAFT residual group) 3.34 (b, 2H, -
SC(=S)S-CH2C3H7), 1.06-2.45 (b, methylene and methine protons of poly(NIPAM) backbone), 1.12 (b, 
methyl protons of poly(NIPAM) repeating units), 0.90 (b, 6H, methyl protons of RAFT residual group). 
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Synthesis of pyridine disulfide functionalized poly(NIPAM43)-PDS  
PNIPAM43-SC(=S)SC4H9 (Mn,SEC = 4200, 0.29 g, 6.0 x 10-5 mol), AldrithiolTM-2 (66 mg, 3.0 x 10-4 
mol) and TEA (40 mg, 1.8 x 10-4 mol) were dissolved in 5 ml DMF. The solution was purged by Ar for 
20 min, and hexylamine (40 mg, 1.8 x 10-4 mol) was then added via a gas-tight syringe. After stirring 
overnight at room temperature, the reaction mixture was blown with air to remove some of the DMF. 
The residual DMF solution was then dissolved in dichloromethane and the polymer precipitate in 
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diethyl ether. The dissolution/precipitation operation was repeated three times and filtered. The polymer 
was then dried under vacuum at room temperature for 48 h to give 0.22 g of white powdery product 
with yield as 75.8%. 
1H NMR (CDCl3, 298K, 500 MHz); δ 8.45 (b, 1H, pyridine proton), 7.63 (b, 2H, pyridine protons), 
7.13 (b, 1H; pyridine proton), 6.47 (b, -NH-C=O- of poly(NIPAM) repeating units), 3.97 (b, -NH-
CH(CH3)2 of poly(NIPAM) repeating units), 3.66 (b, 3H, CH3O- RAFT residual group) 3.46 (b, 1H, 
methine proton close to the disulfide linkage), 1.36-2.10 (b, methylene and methine protons of 
poly(NIPAM) backbone), 1.12 (b, methyl protons of poly(NIPAM) repeating units), 0.88 (b, 3H, methyl 
protons of RAFT residual group). See Figure S1 for MALDI-TOF mass spectra and Figure S2 for 1H 
NMR spectrum. 
 
 
Synthesis of poly(NIPAM43)-protein (eGFP, mCherry, Fibronectin and Vitronectin)  
Recombinant proteins (eGFP and mCherry) or ECM peptides (fibronectin and vitronectin) were 
produced as previously described,5, 26 and sequences shown in Supplementary Table S2. The 
poly(NIPAM43)-PDS was dissolved in Milli-Q water at a concentration of 10 mg/mL. The 
poly(NIPAM43)-PDS solution was added to the protein solutions (at the required concentration), so that 
a 3:1 molar ratio of polymer to protein was achieved. The reaction mixtures were slowly shaken 
overnight at 4 oC. The conjugation efficiency was measured by UV-Vis Spectrometry. Protein solution 
before conjugation was used as background. The absorbance at 340 nm was ascribed to the 
pyridinthione, which was released from the conjugation reaction of PNIPAM-PDS with the proteins, 
and this small molecule was used to quantify the conjugation efficiency. For GFP, Cherry, Fibronectin 
and Vitronectin, the conjugation efficiencies were 100%, 91.5%, 87.5% and 34.1% respectively. 
Proteins conjugated to PNIPAM are designated PNIPAM-b-GFP, PNIPAM-b-Cherry, PNIPAM-b-VN 
and PNIPAM-b-FN. 
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RAFT-mediated emulsion polymerization of styrene with PNIPAM43-SC(=S)SC4H9.  
A typical polymerization was performed as follows: PNIPAM43-SC(=S)SC4H9 (0.350 g, 7.4×10-5 mol, 
5 wt%), SDS (0.0145 g, 5.0×10-5 mol) and Milli-Q water (6.25 g) were added to a 10 mL Schlenk tube 
equipped with magnetic stirrer bar. To dissolve the polymer, the solution was cooled below the LCST of 
PNIPAM by placing the flask in an ice bath. The polymer solution was purged with argon for 40 min. A 
mixture of styrene (0.350 g, 3.4×10-3 mol, 5 wt%) and AIBN (1.2 mg, 7.3×10-6 mol) was added to the 
cooled polymer solution. The reaction mixture was purged with argon for another 10 min, and the 
polymerization heating in an oil bath at 70 °C for 3 h. (SEC: Mn=8300, PDI=1.10) . 
 
A 3 mL latex solution was added to a preheated glass vial with 60 μL of toluene as plasticiser. The 
mixture was shaken for 10 s and cooled to 25 oC to form the worm structures (see Figure S4A and B). 
The resulting polymer dispersion suspension of polystyrene conjugated PNIPAM was then freeze-dried 
to recover the polymer. The worm structures were designated pBridges. See Figure S3 for SEC traces 
and Figure S4 for TEM and SEM images of worms 
In vitro and in vivo cell culture: 
Human embryonic stem cell culture 
All mammalian tissue culture reagents described here were from Life Technologies (Carlsbad, CA, 
USA) unless otherwise stated. hESC lines used were NKX2-5 (eGFP/w) (hES3 background, a kind 
donation from Andrew Elefanty and Ed Stanley27), H9 (WiCell, Wisconsin, MI, USA), MEL1 and 
MEL2 (referenced in5). NKX2-5, MEL1 and MEL2 were maintained by Stem Core Queensland and 
routinely supported as manually passaged cultures on MEF feeder layers as previously described.3  Prior 
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to experiments, cells were adapted to single cell passage as previously described28 in Knockout serum 
replacement media containing 4 ng/mL basic fibroblast growth factor (bFGF) and 0.1mM β-
mercaptoethanol (Sigma-Aldrich, Grand Island, NY, USA). 
Creation of fluorescent PNIPAM surfaces 
A mixture of 35 µL of worms (30% w/v) in PBS was combined with 35 µL combinations of pGFP 
and pCherry in PBS (ranging from 0-70 μg of each fluorescent polymer). This solution was then spun 
coat at 4000 rpm for 30 s onto a 13 mm diameter glass slide, which was previously cleaned and washed 
with 70% ethanol.  The spin coating instrument used was a Headway Research Spinner (PWM32, 
Garland, Tx, USA).  The amounts of each fluorescent polymer bound to the surface was measured using 
a SpectraMax M5 Multi Mode Microplate Reader (Molecular Devices, Sunnyvale, CA, USA) with 
excitation of 485nm or 587nm and emission of 530nm or 610nm for pGFP and pCherry, respectively. 
2 Component ECM PNIPAM surfaces for cell attachment 
A mixture of 35 µL of worms (30% w/v) in PBS was combined with 35 µL of PNIPAM-b-VN or 
PNIPAM-b-FN in PBS (ranging from 0-50 μg of each ECM polymer conjugate). These solutions were 
spun coat at 4000 rpm for 30 s onto organ culture dishes (15 mm diameter tissue culture surface, BD 
Biosciences, Franklin Lakes, NJ, USA). Single cell suspensions of MEL1 or MEL2 cells were plated in 
StemPro® media at 5 × 104 cells per dish. After 2 h binding, unbound cells were washed from the 
surface with warm PBS at 37 oC. Images were taken on an EVOSfl inverted microscope (Advanced 
Microscopy Group, Bothell WA) at 20× magnification and cells counted manually29.  
Cell sheet engineering and enzyme free detachment 
An organ culture dish prepared above with 50 μg of either PNIPAM-b-VN or PNIPAM-b-FN were 
seeded with MEL1 or MEL2 cells at 1 × 106 cells/dish, and cultured for 24 h to allow cell junctions to 
form. The dishes were removed from the 37 oC incubator, and left at RT (i.e. below the LCST of the 
PNIPAM) for 30 min to allow release of cell sheets. Cells were also seeded at low cell density (1 x 
105/dish) to further demonstrate enzyme-free detachment and released below the LCST after incubation 
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at ~4 oC. Geltrex™ (0.5% v/v in DMEM-F12) coated onto the organ culture dishes were used as the 
control. 
hESC embryoid body (EB) formation with PNIPAM-b-VN and pBridges 
MEL1, MEL2 and NKX2-5 were used to form embryoid bodies (EB) in APEL media using the spin 
EB process as previously described30 with some modifications. Briefly, 50 μL of cell suspensions 
containing 3500 cells were seeded per well in a round bottom 96-well plate at RT. Concentrations of 
pBridges (156 μg/mL), PNIPAM-b-VN (14 μg/mL) and bFGF (100 ng/mL) were added to the cell 
suspension. Plates were then centrifuged at 37 oC at 480 g for 5 min. Cells were incubated at 37 oC 
under a 5% CO2 and 5% O2 atmosphere. On day 3, EBs were incubated at RT for 30 min prior to gentle 
pipetting to break apart the EBs. Dissociation of EBs was scored based on 4 categories represented in 
Figure 3A. 
Spin EB formation and dissociation in the absence of polyvinyl alcohol 
APEL media was made as previously described except polyvinyl alcohol (PVA) was removed and the 
equivalent volume replaced with F-12 nutrient mix. PVA-free media was designated AEL. pBridges (0-
1560 μg/mL) and PNIPAM-b-VN (0-50 μg/mL) were added to AEL media with 100 ng/mL bFGF. EBs 
were scored for efficient formation on day 1 based on uniformity of density, spherical EB structure and 
smoothness of EB boundary. Based on a dilution series of PNIPAM-b-VN and worms, an optimal 
concentration of 50 μg/mL and 1.56 ng/mL, respectively, were chosen for EB formation in the absence 
of PVA. 
3D hESC expansion with PNIPAM-b-VN and worms 
Based on a dilution series of PNIPAM-b-VN and worms, an optimal concentration of 50 μg/mL and 
1.56 ng/mL, respectively, were chosen for EB formation in the absence of PVA. NKX2-5, MEL2 and 
H9 were used for 3D expansion with maintenance of pluripotency over 18 days. Media used for Spin 
EB formation were AEL or StemPro® hESC SFM31 with and without BSA. AEL and StemPro® hESC 
SFM were supplemented with 100 and 10 ng/ml bFGF, respectively. Plates and cells were centrifuged at 
37 oC at 480 g for 5 min. Cells were incubated at 37 oC under a 5% CO2 and 5% O2 atmosphere. . EBs 
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were passaged on days 3 and 10. During the first passage on day 3, all 50 μL of media in each well of 
the 96-well-plate was aspirated. EBs were next broken up by gentle resuspension via manual pipetting 
using 150 uL of fresh RT media. The cell suspension was then split into 3 new wells of 50 μL each. The 
process was repeated for a second passage on day 10 to yield an eventual 9 fold increase in culture 
volume on day 18. Positive controls for qPCR and flow cytometry were 2D cultures either on MEF 
feeder layers in KSR media or feeder free in StemPro® media on VN at 20 µg/cm2 as described5. 
Embryoid body (EB) morphology and cell growth kinetics 
Bright field pictures of EBs were taken using an EVOSfl inverted microscope (Advanced Microscopy 
Group) on days 10, 11 and 18. EB diameters were measured in µm using Image J (v1.41). Sixty EBs 
were sized per replicate per condition totalling 180 per condition. For cell counts, a selection of EBs 
were dissociated using TrypLE and stained with Trypan Blue for dead cell exclusion before counting on 
a haemocytometer. 
Quantitative PCR 
The full protocol used closely adheres to recent guidelines on conducting and reporting on qPCR 
results32. RNA extraction and DNA removal was performed using the Qiagen RNeasy RNA extraction 
kit (Qiagen) and on column DNASE set. Briefly, RNA was extracted from hESC at Day 18 post 
expansion or from differentiating cells at varying time points as indicated in figures. One microgram of 
DNA free RNA was converted to cDNA using Life Technologies’s Superscript III First Strand Sythesis 
Supermix. CDNA was diluted 1:10 before qPCR. Primer sequences used for qPCR can be found in 
Table 1. QPCR was performed using an Applied Biosystems 7500 Fast ThermoCycler and SYBR Green 
Master Mix as described33. Primer-product specificity was confirmed by the presence of one peak in a 
step-wise melt curve analysis. Fold change representation was determined relative to hESC grown on 
MEF. All genes of interest were referenced to 3 housekeeping genes:  human β-actin, HPRT and 
GAPDH34 using the Pfaffl method35. All experiments and qPCR runs were conducted in triplicate. 
Flow cytometry 
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Cells were fixed in 4% formalin upon dissociation and stained overnight at 4 oC with primary 
antibody mouse IgG1κ anti- Oct-4 (2 µg/mL) (Merck Millipore). Isotype specific secondary antibody 
conjugated to Alexa fluor 488 was used at 1 µg/mL. Expression of pluripotent marker Oct-4 was 
determined by flow cytometry using a C6 Accuri flow cytometer with Sampler arm (BD Biosciences). 
Data was analysed using CFlow Sampler software (v1.0.264.15, BD Biosciences). 
Cell differentiation 
To assess the differentiation ability of hESC expanded in the presence of PNIPAM-b-VN and 
pBridges, EBs were collected on Day 18 and differentiated as described below and in Figure 1. 
Mesoderm lineages 
For endothelial specific lineage differentiation, EBs were transferred to APEL supplemented with 20 
ng/ml bone morphogenetic protein (BMP-4) (R & D Systems, Minneapolis, MN, USA), 40 ng/ml 
vascular endothelial growth factor (VEGF), 30 ng/ml of stem cell factor (SCF), 20 ng/ml of activin A 
and 100 ng/ml Wnt3a (all from PeproTech, Rehovot, Israel) for 3 days. Media was replaced with APEL 
only for a further 7 days before dissociation of EBs to single cells and transfer to Geltrex coated plates 
(as per manufacturer’s instructions) in EBM-2 medium (Lonza, Mt Waverley, VIC, AU). EBM-2 was 
supplemented as per manufacturer’s instructions and with 10 μM ROCK inhibitor (Stemgent, 
Cambridge, MA, USA). Media change was done every other day. Cells were examined for 
CD31/PECAM on day 21.  
 For cardiac lineage specification, EBs were differentiated as per endothelial cell requirements until 
day 3 then media replaced with APEL supplemented with 5 µM IWP4 (Wnt inhibitor, Stemgent) and 10 
ng/ml VEGF (PeproTech) for another 7 days. On day 10, EBs were refreshed in APEL only and 
observed daily under an EVOSfl inverted microscope (Advanced Microscopy Group) for spontaneously 
beating EBs (H9 and NKX2-5) or GFP representing NKX 2-5 expression 27. 
Endoderm lineages 
EBs pooled together were resuspended in APEL media supplemented with 100 ng/ml Activin A 
(PeproTech) for 5 days with a media change every other day36. After which, EBs were dissociated by 
 14 
TrypLE and transferred to DMEM without bFGF supplemented with 10% fetal bovine serum (FBS) and 
10 µM ROCKi and seeded onto Geltrex™ coated tissue culture plastic for a further 3 days. 
Alternatively, EBs in APEL media were treated with 100 ng/ml Activin A (PeproTech) for 3 days, 
dissociated and transferred to Geltrex™ coated plastic in KSR media supplemented with 10 µM ROCKi 
and 10 ng/ml bFGF (Invitrogen) until day 837.  
Ectoderm lineages 
For neural specific differentiation, EBs were pooled and media was changed to KSR supplemented 
with 100 ng/mL bFGF, 5 mM dorsomorphin, 10 µM SB431542 (Stemgent) and grown for 9 days with 
media changed every other day. On day 10, media was switched to KSR and EBs grown for up to 30 
days prior to plating on Geltrex™ coated tissue culture plastic to allow for neural outgrowth. 
Spontaneous differentiation 
Media was exchanged for DMEM without bFGF and supplemented with 10% FBS. Cells were grown 
for up to 14 days to promote germ layer spontaneous differentiation with a media change every other 
day before cells were fixed and stained as described below. 
Immunofluorescence 
Differentiated cells were fixed at time points relevant for the marker and lineage of interest as 
indicated in Figure 5A. Cells were fixed in 4% formalin and stained overnight at 4 oC as described5. 
Primary antibodies used were mouse IgG2a anti-α- fetoprotein (AFP, 2 µg/mL), rabbit IgG anti-nestin (5 
µg/mL), mouse IgG2a anti-PECAM-1, clone P2B1 (1 µg/mL), mouse IgG1 anti-MAP-2C (5 µg/mL), 
mouse IgG1 anti-β3- tubulin, mouse IgG2a anti-human alpha smooth muscle actin (1 µg/ml) (all from 
Merck Millipore), mouse IgG1 anti-FOXA2 (Abcam), mouse IgG1 anti-human SCF/c-kit-APC (R&D 
Systems) (10 µg/ml), mouse IgG1 anti-human VEGF R2/KDR-Phycoerythrin (50 µg/ml).  Isotype 
specific secondary antibodies were used conjugated to Alexa fluor 488, 568, 633 or 647. Secondary 
antibodies were used at 1 µg/mL. Nuclei were counter stained with DAPI at 1 µg/mL. Fluorescence was 
visualised using an EVOSfl inverted microscope. 
Karyotype Analysis 
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Karyotyping analysis was conducted on NKX2-5 and H9 on day 18 as previously described7. 15 
metaphases per sample were analysed and images taken at a resolution of 400bphs. Karyotype analysis 
was conducted by Sullivan Nicolaides Pathology, Taringa, Australia. 
Toxicity assay 
hESC were grown for 24 hours in StemPro® on Geltrex™ coated plates in the presence of worms in 
suspension at 1.5 or 10.5 mg/mL. At 24 hours cells were harvested using TrypLE and stained with 
propidium iodide (10 µg/mL, Life Technologies) and anti-Annexin V antibody conjugated to Alexafluor 
633 (Life Technologies) to detect early apoptotic cells. Cells were cultured in the presence of 
hydroxyurea (Sigma-Aldrich, St Louis, MO, USA) at 2.5 mM for 24 hrs as positive controls. 
Statistical analysis 
Statistical analysis was conducted using two-tailed paired student’s t-tests. P values <0.05 were 
considered significant. All experiments were performed with a minimum of 3 biological replicates and a 
minimum of 3 inter-experiment replicates 
RESULTS  
Preparation of thermoresponsive worms and PNIPAM-protein conjugates 
To prepare thermoresponsive worms and PNIPAM-protein conjugates, PNIPAM43-SC(=S)SC4H9  
was first synthesized by RAFT polymerization at 60 oC in DMSO with narrow polydispersity as 1.09. 
For the synthesis of pBridges, PNIPAM43-SC(=S)SC4H9 was used as MacroCTA for the RAFT-
mediated emulsion polymerization of STY in water at 70 oC. The resultant emulsion latex was then 
cooled down from 70 to 25 oC in the presence of small amount of toluene plasticizer. The worm 
structures (denoted as pBridge) were further confirmed by TEM and SEM (see Figure S4 A and B). This 
method allowed preparing worm-like nanobridge structures up to 10 wt% that could be freeze-dried and 
rehydrated without morphology reorganization.23 For the synthesis of PNIPAM-protein conjugates, the 
RAFT end-group (i.e. trithiolcarbonate) of  PNIPAM43-SC(=S)SC4H9 was first converted to pyridyl 
disulfide (PDS) functional group by in situ aminolysis and thiol protection with dipyridyl disulfide. The 
resulted PNIPAM-PDS was characterized by 1H NMR and MALDI-ToF mass spectrum (see Figure S1 
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and S2). The PDS group were then reacted with the free thiol group on the protein to form PNIPAM-
protein conjugates. The release of 2-pyridylthione, which has a typical UV-vis absorbance at 340 nm, 
was used to quantify the conjugation efficiency. In this work, we conjugated PNIPAM-PDS with GFP, 
Cherry, FN, and VN, respectively and the resulted PNIPAM-protein conjugates were designated as 
PNIPAM-b-GFP, PNIPAM-b-Cherry, PNIPAM-b-FN and PNIPAM-b-VN. 
hESC attachment to the thermoresponsive worms on 2D surfaces. 
The ability for the PNIPAM chains functionalized with protein to adsorb to and thus functionalize the 
surface of the worms was tested using two recombinant fluorescent proteins coupled to PNIPAM: (i) 
PNIPAM-b-GFP, and (ii) PNIPAM-b-mCherry (see Table S2 in SI for protein sequence). These two 
fluorescent diblocks were mixed in different ratios and heated above the LCST in the presence of worms 
and spun coated on a 2D culture dish (see schematic representation in FigureS5A in SI). The fluorescent 
signal ratio from each diblock on the surface was identical to the initial concentration input of diblock 
ranging from 0 to 70 μg/13 mm slide (Figure S5B in SI). There was a linear increase in fluorescent 
signal for both PNIPAM-b-GFP (R2 = 0.97) and PNIPAM-b-Cherry (R2 = 0.99) as shown in Figure S5B 
in SI. The results demonstrated the near quantitative physical adsorption of the PNIPAM-b-protein 
copolymers to functionalize the surface of the worms. 
The biocompatibility and toxicity of the worms were tested with two hESC lines: MEL1 and MEL2. 
HESCs were cultured on Geltrex in the presence of worms at two concentrations (1.5 mg/mL or 10.5 
mg/mL) or with the cytotoxic hydroxyurea agent. There was no significant increase in cell death or 
activation of early apoptosis pathways in the presence of worms (Figure S5C in SI), suggesting that the 
hESCs, which are generally sensitive to even simple changes in culture processes, were not affected by 
the presence of worms.  
2D attachment of hESCs in the presence of worms and PNIPAM-b-ECM. 
Two-dimensional surfaces coated with a combination of worms and a diblock copolymer (consisting 
of an ECM fragment covalently coupled to the chain end of PNIPAM) were first used to test the binding 
and release of hESCs. At a temperature above the LCST, the spun coated worms adsorbed the diblock, 
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thus creating an ECM-functionalized 2D surface (same process as depicted in Figure S5A in SI). The 
ECM fragments consisted of either Vitronectin (VN; with an RGD motif and a SMB domain),5 
Fibronectin (FN; Type II, domains 7-10)38 or the short RGD integrin binding motif. These were coupled 
to PNIPAM via a disulfide linkage to form diblock copolymers of PNIPAM-b-VN, PNIPAM-b-FN and 
PNIPAM-b-RGD, respectively. The binding efficiency of MEL1 and MEL2 hESC lines to PNIPAM-b-
VN or PNIPAM-b-FN adsorbed onto worms coated 2D surfaces increased with protein concentration 
(Figure 2A). Maximum cell binding was achieved between 20 and 50 μg of PNIPAM-b-ECM/well, 
similar to results for VN surfaces previously reported.5 Cells did not bind to uncoated glass slides 
(Figure 2I and J) nor to surfaces coated with only worms (not shown). In addition, cells did not bind to 
worm surfaces adsorbed with PNIPAM-b-RGD (Figure S5D in SI) in agreement with previous studies 
that showed small RGD containing peptides alone were not sufficient to support hESC.6 The variations 
in binding efficiency to PNIPAM-b-VN/worm surfaces observed between MEL1 and MEL2 suggests 
variability between the cell lines of cell surface integrin expression responsible for binding to VN.  
Importantly, our system has the capacity for the amount of protein displayed on the worms to be finely 
tuned for maximum binding of different cell lines. 
PNIPAM coated surfaces used in tissue culture have previously provided an enzyme-free detachment 
of cells from a surface through a decrease in temperature below PNIPAMs LCST.16, 21, 39 A decrease in 
temperature below the LCST results in a globule to coil transformation of the PNIPAM chains to a 
hydrophilic state, releasing the cells from the surface. When we seeded cells at high density (~1 
×106/1.8 cm2) grown on PNIPAM-b-ECM /worm 2D surfaces, confluent sheets formed after 24 h. The 
confluent layers of hESC were cooled to RT and left for 20 min, resulting in complete release of cell 
sheets from the surface without any manual intervention (Figure 2B). In contrast, cells on the Geltrex 
substrate remained attached and could not be released (data not shown). Single cells could also be 
released from the surface seeded with ~5 ×104 cells/1.8 cm2. Cooling to 4 oC (i.e. < LCST) for 1 h 
resulted in spontaneous cell detachment from the worm surfaces adsorbed with either PNIPAM-b-FN 
(Figure 2H) or PNIPAM-b-VN (Figure 2K), producing the distinctive cell rounded morphology (inset in 
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Figures 2H and 2K). The remaining cells bound to the surface could be removed with gentle aspiration 
of the media (data not shown). In contrast, cells coated on the Geltrex surface exhibited no cell 
detachment or change in cell morphology upon low-temperature incubation (Figure 2C-E). Taken 
together, the data showed that the combination of worms and PNIPAM-b-ECM facilitated both cell 
binding and enzyme- and mechanical-free cell detachment. 
Embryoid body (EB) formation in the presence of worms and PNIPAM-b-VN. 
First, optimum conditions were established for EB formation and dissociation in APEL (albumin, 
polyvinylalcohol, and essential lipids)30 media in the absence and presence of PNIPAM-b-VN and 
worms. The VN ECM fragment has previously been shown to sustain long term undifferentiated 
expansion of hESC,5 and thus used in the EB work. The morphology of the initial EBs with and without 
PNIPAM-b-VN/worms were indistinguishable (data not shown). After 3 days of growth, the EBs were 
treated by manual pipetting either at 37 oC or incubated at RT for 20 min. The EBs after this treatment 
were imaged and grouped into 4 classifications: (i) unbroken, (ii) partial, (iii) clumps and (iv) small 
clumps as shown in Figure 3A. At 37 oC (i.e. above the LCST), the presence of PNIPAM-b-VN and 
worms did not alter the levels of EB dissociation compared to the APEL control (Figure 3B). During 
incubation at RT (i.e. below the LCST), EBs with the polymer components showed a 30% increase in 
EB dissociation (p<0.05, paired t-test, n = 48, Figure 3B), representing a statistically significant 
enhanced dissociation using the thermoresponsive polymer components. The types and percentages of 
the dissociation of EBs at room temperature given in Figure 3C showed that in the presence of the 
polymer components nearly all EBs dissociated into partial, clumps and small clumps as compared 
~40% EBs remaining unbroken in the absence of polymer. It was also observed that in the presence of 
the polymer components, a significantly greater percentage of EBs dissociated to small clumps 
compared to APEL alone. Therefore, the thermoresponsive polymer system allowed dissociation 
without the need for enzymes or calcium chelators (e.g. EDTA).  
Poly(vinyl alcohol) (PVA) is an essential ingredient in APEL to nucleate and thus facilitate EB 
formation by essentially gluing the cells together.30 Removing PVA from the media (i.e. an AEL media) 
 19 
without the thermoresponsive polymer components gave no EB formation in our experiments and a 
minimum concentration of 0.5% (w/v) PVA was required for EB formation (data not shown), which 
was consistent with Ng and colleagues.30 We sought to investigate whether our thermoresponsive 
polymer components could replace PVA and provide a biologically relevant attachment matrix and 
nucleation point for the formation of NKX2-5 hESC EBs. In an AEL medium (i.e. without PVA), the 
minimum concentration of PNIPAM-b-VN required for EB formation was 6.25 μg/mL (Figure 3D). At 
concentrations of worms above 15.6 μg/mL, EB formation was inhibited. The most consistent formation 
of EBs occurred at PNIPAM-b-VN and worm concentrations of 50 μg/mL and 1.56 ng/mL, 
respectively. This optimal concentration of the polymer components further resulted in improved EB 
dissociation on day 3 at RT as compared to the APEL controls (Figure 3E). The hESC line MEL2 
displayed similar results in formation and dissociation as those for the NKX2-5 cell line (data not 
shown). 
Enzyme free, 3D expansion of hESC 
Expansion of hESCs and differentiated progeny on tissue culture surfaces for therapeutic applications 
is limited due to scalability constraints and increased cell death during passage as a result of anoikis.9, 13, 
14 In this study, we overcame this limitation by growing and expanding hESCs in 3D EB suspension 
cultures in the presence of PNIPAM-b-VN and worms and utilizing the passaging methodology 
described in Figure 1B. Three hESC lines, MEL2, NKX2-5 and H9, were cultured and expanded 
utilizing this methodology for 18 days in AEL or StemPro (SP) media using PNIPAM-b-VN (50 
μg/mL), worms (1.56 ng/mL) and bFGF (100 ng/mL and 8 ng/mL for AEL and SP, respectively) with 
the results given in Figure 4 and Figure S6 in SI. EBs were formed at 3,500 cells/EB, and on days 3 and 
10 the EBs were passaged using gentle pipetting at temperatures below the LCST to form small clusters. 
The cultures were then equally split into three new wells with new media (AEL or SP) and with or 
without PNIPAM-b-VN and worms.  
The NKX2-5 EBs grown in APEL media for 18 days without being passaged (i.e. the control) showed 
a slow 4-fold growth after 10 days that decreased slightly at day 18 (Figure 4). This trend was also 
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observed for the MEL2 and H9 cell lines (Figure S6 in SI), highlighting that once an EB reached a 
critical size limit (or cell number limit) further growth was inhibited. The NKX2-5 EB growth and 
passaging in SP media with and without BSA showed a relatively linear growth over the 18 days with a 
final 13.8±2.6 and 7.1±3.5 (n=3) fold growth, respectively (Figure 4). In any pNIPAM condition, cell 
loss at passage/ during inoculation of new plates, was not below 20% (not shown). This is better than or 
equivalent to current published methods where cell death at inoculation ranged from 18% to as high as 
58%.40 In the presence of the thermoresponsive polymer components, the fold growth increased 
exponentially in SP media over the 18 days to 20.1±12.6 and 31.4±12.6 without and with BSA in the 
media, respectively. The combination of the thermoresponsive polymer components and BSA in SP 
media was essential for the predictable and large fold growth not only for NKX2-5 cells (which 
followed the theory curve closely) but also for the H9 cell line with a 34-fold growth after 18 days 
(Figure S6C in SI). Without BSA, the H9 cell line failed to grow.  
The average diameter of the NKX2-5 EBs in SP media (with BSA) before passage (i.e. before 
dissociation) on day 10 was close to 400 µm, a size that remained unchanged after passage on day 11 
and further culturing to day 18 (Figure 5A). The presence of the polymer components (worms and 
PNIPAM-b-VN) resulted in a decrease in the average diameter of the EBs from 511±131 μm before 
passaging on day 10 to 216±91 μm on day 11, and after further cell growth the EB increased in size to 
404±149 μm on day 18. A more detailed analysis of the individual EB diameter distribution revealed in 
cultures without the thermoresponsive polymer components there was a small change in the size 
distribution from day 10 to day 11 (i.e. before and after passaging), ranging from 80-640 μm (Figure 
5B). In contrast, it was clearly observed that the EBs cultured with the thermoresponsive polymer 
components decreased the main size distribution between 480-640 μm at day 10 to 80-320 μm after 
passage on day 11. Similar results were found using H9 hESCs (Figure S8A and B in SI). This data 
supports the postulate10 that it is paramount to keep the EBs below a size where the diffusion of growth 
factors and other nutrients is homogeneous across the EB cross-section. Our passage method allows the 
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EBs to be dissociated when they reach this size and these smaller cell aggregates to be further grown to 
provide the opportunity for exponential cell expansion.  
The ability to maintain pluripotent marker expression after 18 days is a key parameter to a successful 
hESC expansion. NKX2-5 (Figure S7A and B) and MEL2 EBs (not shown) after 18 days of culture in 
AEL with the polymer components and high levels of bFGF failed to maintain pluripotency marker 
expression as measured by either qPCR or flow cytometry. However, when NKX2-5 and H9 cell lines 
were cultured in SP (with or without BSA, p>0.05, Figure 5C and Figure S8C in SI, respectively) there 
was no significant change in gene expression levels for pluripotency markers Oct4 or Nanog compared 
to 2D MEF controls. Interestingly, the expression of Oct4 protein from the NKX2-5 cell line in different 
media as measured by flow cytometry was down regulated compared to positive controls (Figure 5D). 
In APEL, the Oct4 protein expression was low but increased when the media was changed to SP. The 
best result of 78±3.4% Oct4 protein expression was found when the NKX2-5 EBs were cultured in SP 
with BSA and the thermoresponsive polymer components, suggesting inclusion of worms and 
PNIPAM-b-VN may in fact assist in the maintenance of pluripotency and thus the expansion of 
pluripotent cell populations. H9 cells in SP BSA with the thermoresponsive polymer components 
showed a similar improvement but were lower at 64.5±18.4% Oct4+ (n=3, Figure S8D in SI) on day 18. 
The culture conditions could be further optimized to facilitate expansion of H9 with improved 
pluripotent marker expression by changing the types of ECM and growth factor proteins conjugated to 
PNIPAM in combination with PNIPAM-b-VN. 
The capacity for cells grown in the presence of PNIPAM-b-VN/worms (in SP and BSA) was 
demonstrated by the in vitro or in vivo differentiation and karyotype assessment after 18 days of 
expansion. Both H9 and NKX2-5 maintained a stable karyotype (H9 in Figure 6B and NKX2-5 not 
shown). Both cell lines were subjected to lineage or cell specific differentiation in vitro (Figure 6A) and 
were positive for markers specific to all three germ lineages including nestin and β-3-tubulin 
(ectoderm), CD31, cardiac troponin and NKX2-5 (mesoderm) and Foxa2 (endoderm) (Figure 6C). In 
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addition, both cell lines were capable of forming beating cardiomyocyte clusters (Supplementary Video 
S1 and S2) and forming cell structures in vivo representative of all three germ lineages (Figure 6C). 
DISCUSSION 
Over recent years, a large number of systems have been developed to create more defined surfaces for 
stem cell culture through biomimetic or biofunctionalised 2D surfaces.2, 5, 6, 41 However, the creation of 
scalable systems for stem cell expansion has been hampered by the requirement of cells to grow in 
contact with both other cells and an ECM substrate. We have created a two component 
thermoresponsive polymer system to aid in both the formation and de-aggregation of 3D hESC EBs 
grown in a commercial culture media. The thermoresponsive polymer worm structures range in length 
from 0.5 to 3 µm and represents an ideal length to bridge cells. These wormss together with PNIPAM 
diblock co-polymers functionalized with a recombinant fragment of the ECM protein, vitronectin 
(PNIPAM-b-VN) represents a new thermoresponsive polymer system for the reversible EB formation 
and breakdown. First, at a temperature below the LCST, the PNIPAM-b-VN binds to the cell surface 
through its integrin receptors, functionalizing the cell surface with hydrophilic PNIPAM chains (Figure 
1A). Increasing the temperature to 37 oC (i.e. above the LCST), the cells aggregate through self-
adsorption of the PNIPAM onto the surface of both the worms and cells. This process is reversible by 
cooling below the LCST. The temperature responsive polymer system of cell aggregation and release 
allowed a new method for the expansion of hESCs using EBs, having multiple advantages over current 
2D and 3D methodologies. First, temperature instead of enzyme or chemical treatment is used for 
dissociation of cells, helping maintain cell surface protein-ECM and cell-cell contact responsible for cell 
survival and proliferation. The use of enzymes disrupt these contacts leading to cell death12-14 or poor 
proliferation of cells. Second, the size of the EBs can be controlled to provide penetration of growth 
factors and nutrients through the EB for facile expansion. Third, a significant advantage in our method 
lies in the ability to tune the type, amount and combinations of PNIPAM-b-ECM bound to the cell 
surface to suit the application or specific cell line.  
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The use of hESC and their differentiated progeny for therapeutic applications will require a defined 
culture system that is reproducible and amenable for many different hESC lines and applications. 
However, due to the variability in response of different hESC lines to a given culture condition, the 
development of culture media and conditions suitable for all hESC lines can be problematic. Our 
research has highlighted some of the differences in both attachment of different hESC lines to the ECM 
(compare MEL1 and MEL2, Figure 2A) and their response in proliferation and maintenance of 
pluripotency under similar growth conditions (compare NKX2-5 and H9 maintenance of Oct4, Figure 
5D and Supplementary Figure S8D). We have shown that different proteins conjugated to PNIPAM can 
be reliably applied at different concentrations (Figure S5B in SI) in varying combinations providing a 
distinct advantage of being able to optimize the culture for individual cell lines or lineage specific 
differentiation with no toxic effects to the cells or inhibition of cell-ECM interactions. This attribute will 
also facilitate the use of increasingly simplified media compositions, such as the E8 media,42 recently 
formulated for the scale up of undifferentiated hESC on a vitronectin substrate and their use in future 
therapeutic applications. Basic media formulation can then be combined with the required ECM or 
proteins conjugated to PNIPAM, optimizing growth conditions for a specific application or cell line, 
while still allowing the growth and non-invasive sub-culturing and scale-up of the cell line. 
 
CONCLUSION 
We have prepared a two component polymer system for the enzyme free propagation of hESC in 
suspension culture. The first component consisted of long and flexible worms with a glassy polystyrene 
core coated with thermoresponsive PNIPAM chains. The second component consisted of a block 
copolymer of PNIPAM and a recombinant vitronectin subdomain. When this two component PNIPAM 
system was heated to 37 oC in the presence of hESCs, the cells formed EBs, which grew until a size 
where nutrients became limiting. At this stage the temperature of the culture was reduced, facilitating 
together with gentle pipetting breakdown to smaller sized cell aggregates. The thermoresponsive nature 
of the worms enabled a cyclical dissociation and propagation of the cells. After only three cycles (over 
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18 day) there was a greater than 30 fold expansion in cell number. These cells showed they maintained 
pluripotency. This proof of principle study further demonstrates the importance of hESC-ECM 
interactions that can drive maintenance of pluripotency but also enable control of lineage specific 
differentiation. Production of hESC cultures used in this work has the potential for therapeutic use 
through control of environmental and physical conditions.  
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Figure 1. 3D expansion of hESC using thermoresponsive worms. (A) Proposed mechanism for 
temperature reversible hESC 3D clustering (EBs) and release using PNIPAM-b-VN and pBridges (the 
combination of which is denoted as PNIPAM). (B) Schematic representation for expansion and 
aggregation breakdown of hESC EBs using PNIPAM-b-VN and pBridges. (C) Representation for hESC 
expansion with de-aggregation based on the process in graph B: total volume increases  3-fold on each 
passage. 
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Figure 2. Two-Dimensional attachment and release of hESC. (A) Growth of MEL1 and MEL2 hESC 
attached to a 2D surface coated with worms (15% w/v)  and at varying amounts of PNIPAM-b-ECM 
(ECM = vitronectin (VN) or fibronectin (FN)). hESC were allowed to attach for 2 h in SP media before 
gentle washing with PBS at 37 oC to remove unattached cells. Attached cells were removed by cooling 
to room temperature and counted. (B) High density seeding and sheet release of hESCs (1×106/1.8 cm2) 
without manual interference by incubating for 24 h at 37 oC, 5% CO2, and then cooling to room 
temperature for 20 min. (scale bar is 1000 µm). (C-K) Bright field images of hESC detachment from 
pBridge and PNIPAM-b-ECM spun coat surfaces. Organ culture dishes were spun coat with worms 
(15% w/v) and PNIPAM-b-ECM (50 μg/dish). hESCs were allowed to attach for 2 h at 37 oC before 
release at 4 oC. Time release at 4 oC; (C,F,I) Images at 0 min, (D,G,J) images at 30 min, and (E,H,K) 
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images at 60 min. Geltrex™ was used as the control (C-E). Dotted lines represent boundary between 
coated and uncoated glass surface. 
 28 
Figure 3. Optimization of enzyme free propagation of NKX2-5 hESC embryoid bodies (EBs). (A) 
Classification of EB dissociation. EBs were formed using the Spin EB protocol in APEL media with 
worms (156 μg/mL) and PNIPAM-b-VN (14 μg/mL). On day 3, EBs were incubated at RT for 20 min 
before passing through a 200 μL pipette tip to dissociate (scale bar = 1000 μm). (B) Percentage of EBs 
dissociated in various media at RT with gentle titration. (C) Amounts of unbroken, partial, clumps and 
small clump EBs at RT after manual dissociation. (D) EB formation in PVA free media AEL. Score: 1 = 
EB, 2 = partial EB, 3 = clump, and 4 = no EB formation; averaged from 3 independent experiments and 
6 technical replicates within each experiment, n=18. (E) EB dissociation at RT in PVA free media with 
worms and PNIPAM-b-VN. EBs formed in AEL media with worms (1.56 ng/mL) and PNIPAM-b-VN 
(50μg/mL) were dissociated on day 3 and classified according to EB clump sizes as outlined in (A). 
APEL (albumin, polyvinylalcohol (PVA), essential lipids); AEL (albumin and essential lipids). 
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Figure 4. hESC expanison using thermoresponsive polymer system. Total cell count and fold expansion 
of hESCs for NKX2-5 in StemPro (SP) media over 18 days. Initial EBs were formed from 3500 
cells/EB in the absence or presence of BSA, PNIPAM-b-VN (50 μg/mL) and worms (1.56 ng/mL). EBs 
were passaged 1:3 on day 3 and 10 by incubating at RT for 20 min followed by gentle pipetting. EBs in 
APEL were not passaged. Cell counts were performed on days 3, 4, 10, 11 and 18. APEL (albumin, 
polyvinylalcohol, and essential lipids); SP (StemPro without bovine serum albumin, BSA); SP BSA 
(StemPro with BSA); PNIPAM (PNIPAM-b-VN (50 μg/mL) and worms (1.56 ng/mL)). Total cells are 
representative of EBs pooled from 720 wells. 
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Figure 5. Enzyme free, 3D expansion of NKX2-5 hESCs. Initial EBs were formed using 3,500 cells/EB 
in StemPro (SP) media with and without BSA, PNIPAM-b-VN (50 μg/mL) and worms (1.56 ng/mL). 
EBs were passaged 1:3 on day 3 and 10 by incubating at RT for 20 mins followed by gentle pipetting. 
(A) Average EB diameter. Representative images of EB size below the graph. Images are 1000 μm 
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wide. EB diameter was determined using Image J image analysis software. 60 EBs were sized per 
sample, per replicate, n= 180. (B) EB size distribution before and after passage. (C) qPCR analysis of 
Nanog and Oct4 gene expression on day 18. Fold change is relative to hESC grown on MEF feeder 
layers and averaged using three housekeeping genes β-actin, GAPDH and HPRT. Error bars represent 
standard deviation of 3 independent experiments. (D) Oct4 protein expression measured by flow 
cytometry on day 18. SP (StemPro without bovine serum albumin, BSA); SP BSA (StemPro with BSA); 
PNIPAM (PNIPAM-b-VN (50μg/mL) and worms (1.56 ng/mL); APEL (albumin, polyvinylalcohol, 
essential lipids); 2D VN (hESC on tissue culture plastic coated with vitronectin); 2D MEF (hESC grown 
on mouse embryonic fibroblast feeder layers).  
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Figure 6. Characterization of hESCs after 3D expansion in StemPro with BSA, PNIPAM-b-VN and 
worms. (A) hESC differentiation protocols used after 18 days expansion. Day 0 marks the start of 
differentiation after 18 days expansion. (B) Karyotype representations of H9 and Nkx2-5 after 18 days 
expansion. (C) In Vitro and In Vivo differentiation of hESC after 18 days expansion. Scale bars in μm. 
NKX2-5 and H9 cells differentiated in vivo to all three lineages. Representative images for NKX2-5 
shown. Black arrow, centre image pointing to endoderm tissue. Black arrow and white arrow in right 
image pointing to ectoderm and mesoderm respectively. BIIIT; β-3-tubulin, cTnT; cardiac troponin. 
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Video S1: Beating embryoid bodies at day 15 of differentiation derived from NKX2-5 hESC 
On day 18 of culture, EBs grown in SP BSA PNIPAM were transferred to APEL supplemented with 20 
ng/mL BMP-4, 40 ng/mL VEGF, 30 ng/mL SCF, 20 ng/mL of activin A and 100 ng/mL Wnt3a for 3 
days. EBs were washed on day 4 and transferred to APEL supplemented with 5 µM IWP4 and 10 ng/ml 
VEGF for another 7 days. On day 10, EBs were refreshed in APEL only and observed daily under an 
EVOSfl inverted microscope for spontaneously beating EBs and GFP expression representing NKX2-5 
expression. 
 
Video S2: Beating cardiomyocytes at day 15 of differentiation derived from H9 hESC  
On day 18 of culture, EBs grown in SP BSA PNIPAM were dissociated and plated onto tissue culture 
plastic coated with GeltrexTM. Media was exchanged for DMEM without bFGF and supplemented with 
10% FBS. Cells were grown for up to 15 days to promote germ layer spontaneous differentiation with a 
media change every other day. Spontaneously beating cluster began to develop beyond day 10. 
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Table S1. qPCR primer sequences 
Gene Direction Sequence Size bp 
B-Actin Forward GCT GTG CTA CGT CGC CCT G 61 
Reverse GGA GGA GCT GGA AGC 
NANOG Forward CAA AGG CAA ACA ACC CAC TT 158 
Reverse TCT GCT GGA GGC TGA GGT AT 
OCT-4 Forward TGA AGC TGG AGA AGG AGA AG 134 
Reverse ATC GGC CTG TGT ATA TCC C 
GAPDH Forward GAA GGT GAA GGT CGG AGT CA 109 
Reverse AAT GAA GGG GTC ATT GAT GG 
HPRT Forward GGGAGGCCATCACATTGTAG 168 
Reverse TCCCCTGTTGACTGGTCATT 
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Table S2 – Recombinant peptide sequences 
Recombinant 
ECM fragment Sequence 
eGFP 
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQG
KLTVAKLNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFL
DANLAGSGSGSDPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDA
TYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAM
PEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHK
LEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDG
PVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKKLAA
GSGSGYDPEGSGSGHHHHHH 
mCherry 
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQG
KLTVAKLNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFL
DANLAGSGSGSDPMVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGEG
EGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPADIPDYLK
LSFPEGFKWERVMNFEDGGVVTVTQDSSLQDGEFIYKVKLRGTNFPSDGPV
MQKKTMGWEASSERMYPEDGALKGEIKQRLKLKDGGHYDAEVKTTYKAK
KPVQLPGAYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDELYKKLAA
GSGSGYDPEGSGSGHHHHHH 
Fibronectin 
Type II, 
domains 7-10 
MPLSPPTNLHLEANPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEV
VHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPISDTIIPAVPPPTDLRFTNI
GPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLP
GTEYVVSVSSVYEQHESTPLRGRQKTGLDSPTGIDFSDITANSFTVHWIAPRA
TITGYRIRHHPEHFSGRPREDRVPHSRNSITLTNLTPGTEYVVSIVALNGREES
PLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVRYYRITYGETGGNSP
VQEFTVPGSKSTATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYRTSDPN
SSSVDKLAAALEHHHHHH 
Vitronectin 
SMB domain 
MDQESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDYTAECKPQVTRGDVF
TMLEHHHHHH 
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Figure S1. MALDI-TOF mass spectra of poly(NIPAM43)-PDS: (A) the calculated isotopic resolution, 
(B) the measured isotopic resolution, and (C) the full spectrum. 
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Figure S2. 1H NMR of poly(NIPAM43)-PDS in CDCl3 at 500 MHz , * is water. 
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Figure S3. SEC traces of poly(NIPAM43)-RAFT (─) obtained by RAFT-mediated solution 
polymerization in DMSO at 60 oC for 16 h and poly(NIPAM43-b-PSTY38) (─) obtained by RAFT-
mediated emulsion polymerization of styrene in water at 70 oC for 3 h. THF was used as eluent and 
polystyrene standards as the calibration.  
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Figure S4. TEM and SEM images of worms by adding 20 μL toluene to 1 mL of PNIPAM43-b-PSTY38 
latex solution (~7 wt %) obtained via aqueous emulsion polymerization and then cooled from 70 oC to 
25 oC, the worm latex solution was then diluted by adding 7 µL latex to 1 mL of Milli-Q water to give a 
concentration of ~0.05 wt % (A) TEM image with scale bar as 1 µm, (B) SEM image with scale bar as 
100 nm. 
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Figure S5. hESC response to PNIPAM surfaces/solutions (A) Method for fluorescent protein (i.e. 
eGFP and mCherry) surface adsorption onto 2D surfaces spun coat with worms. (B) Fluorescence of 
PNIPAM-b-protein (protein = eGFP or mCherry) adsorbed onto the 2D worm coated surface at varying 
eGFP:mCherry ratios, (n=3). (i) Linear representation of fluorescent protein deposition after spin 
coating. (ii) Dual deposition of PNIPAM-b-protein. Fluorescent proteins conjugated to PNIPAM were 
spun coat together with worms at concentrations and combinations shown. Surfaces were washed then 
fluorescence read using a SpectraMax M5 plate reader. Values are average of n = 3 experiments. (C) 
Analysis of PNIPAM-b-polysytrene toxicity to hESC. MEL1 (shown) and MEL2 were incubated for 24 
hours in the presence of worms at the concentrations indicated. Cells were stained with propidium 
iodide and annexin V-488 and fluorescence measured via flow cytometry on an Accuri C6 cytometer. 
Hydroxyurea (2.5mM) was used to induce cell death as a positive control. (D) hESC attachment to 
PNIPAM-b-ECM/worms spun coat surfaces. Glass slides were spun coat with a consistent concentration 
of worms (15% w/v) mixed with either PNIPAM-b-VN, PNIPAM-b-FN or PNIPAM-b-RGD (50 
μg/mL). hESC were allowed to attach for 2 hours before gentle washing with PBS at 37 oC and imaging. 
Dotted lines represent the boundary of PNIPAM coating with no cell attachment beyond. 
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Figure S6. Fold expansion of hESC grown with PNIPAM. 
Initial EBs were formed using 3,500 cells/EB in APEL, AEL or StemPro (SP) media with and without 
BSA, PNIPAM-b-VN (50 μg/mL) and worms (1.56 ng/mL). EBs in APEL were not passaged. EBs in 
all other media were passaged on day 3 and 10 by incubating at RT for 20 min followed by gentle 
pipetting. Cultures were split 1:3. Cell counts were performed on days 3,4,10,11 and 18. (A) MEL2 in 
AEL media. (B) NKX2-5 in AEL media. (C) H9 in SP media. Cultures without BSA did not survive to 
day 18. APEL (albumin, polyvinylalcohol, essential lipids); AEL (albumin, essential lipids); SP 
(StemPro without bovine serum albumin, BSA); SP BSA (StemPro with BSA); PNIPAM (PNIPAM-b-
VN (50μg/mL) and worms (1.56 ng/mL). Total cells are representative of EBs pooled from 720 wells. 
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Figure S7. Expansion of hESC EBs in AEL with worms and PNIPAM-b-VN (A) qPCR analysis of 
Nanog and Oct4 gene expression for NKX2-5. On day 18, mRNA was extracted from EBs and 
converted to cDNA before qPCR measurement of Oct4 and Nanog expression. Fold change is relative to 
hESC grown on MEF feeder layers and average using three housekeeping genes β-actin, GAPDH and 
HPRT. Error bars represent standard deviation of 3 independent experiments. (B) Oct4 protein 
expression measured by flow cytometry. PNIPAM; cultures with PNIPAM-b-VN 50μg/mL and 
1.56ng/mL worms, APEL; Albumin Polyvinylalcohol Essential Lipids, AEL; Albumin Essential Lipids, 
2D MEF; hESC grown on mouse embryonic fibroblast feeder layers. (C) Teratoma formation of NKX2-
5 after 18 days growth in AEL with worms/PNIPAM-b-VN. Arrows point directly to tissue of interest 
for respective germ lineage. 
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Figure S8. Enzyme free, 3D, pluripotent expansion of H9 hESCs. Initial EBs were formed using 
3,500 cells/EB in StemPro (SP) media with and without BSA, PNIPAM-b-VN (50 μg/mL) and worms 
(1.56 ng/mL). EBs were passaged on day 3 and 10 by incubating at RT for 20 mins followed by gentle 
pipetting. (A) Average EB diameter. EB diameter was determined using Image J image analysis 
software. 60 EBs were sized per sample, per replicate, n= 180. (B) EB size distribution before and after 
passage. (C) qPCR analysis of Nanog and Oct4 gene expression on day 18. Fold change is relative to 
hESC grown on MEF feeder layers and averaged using three housekeeping genes β-actin, GAPDH and 
HPRT. Error bars represent standard deviation of 3 independent experiments. (D) Oct4 protein 
expression measured by flow cytometry on day 18. SP; StemPro, BSA; bovine serum albumin, 
PNIPAM; cultures with PNIPAM-b-VN (50μg/mL) and worms (1.56 ng/mL), APEL; Albumin 
 50 
Polyvinylalcohol Essential Lipids, 2D VN; hESC on tissue culture plastic coated with vitronectin, 2D 
MEF; hESC grown on mouse embryonic fibroblast feeder layers. 
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